Atom based 3D QSAR and Fingerprint based 2D QSAR of Novel Molecules as MmpL3 receptor inhibitors for Mycobacterium tuberculosis
K Poojita1, Fajeelath Fathima1, Rajdeep Ray1, Lalit Kumar2, Ruchi Verma1*
1Department of Pharmaceutical Chemistry, Manipal College of Pharmaceutical Sciences,
Manipal Academy of Higher Education, Madhav Nagar - 576104, Manipal, Udupi, Karnataka, India.
2Department of Pharmaceutics, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Madhav Nagar - 576104, Manipal, Udupi, Karnataka, India.
*Corresponding Author E-mail: ruchi.verma@manipal.edu, ruchiverma_farma@yahoo.com
ABSTRACT:
Tuberculosis is one of the leading cause of increase in mortality rate in today’s health care scenario. Due to increase frequency of drug resistant TB it is prudent to find new targets and promising targets for anti-tubercular activity. MmpL3 (Mycobacterial Membrane Protein Large 3) is one of the most effective and promiscuous targets for development of new drug for anti-tubercular therapy due to its cross resistance inhibition property. In this study we have presented atom based 3D QSAR and finger print based 2D QSAR models to study different structural and functional groups of Adamantyl urea derivatives and their action in MmpL3 inhibitory activity which will provide us the insight for designing better and far more effective anti TB drugs.
KEYWORDS: MmpL3 inhibitors, Atom based 3D QSAR, Fingerprint based 2D QSAR.
INTRODUCTION:
Tuberculosis (TB) is an infectious disease which primarily affects the lungs. This contagious disease is caused by the microorganism Mycobacterium tuberculosis. Tuberculosis is one of the leading cause of death in today’s health care scenario.1
According to Global Tuberculosis Report by WHO in 2018 nearly 10 million people suffered from Tuberculosis with an overall mean of 130 cases per 100,000 population per year.2
Hence, with the increasing prevalence of MDRTB (Multi Drug Resistance TB) and TDRTB (Total Drug Resistant TB) it is of utmost importance to develop new drugs with novel mechanism of action targeting MTb disease.
One of most effective and important target for anti TB drugs is the mycobacterial cell wall. Due to its unique structure it plays a very important role in Tuberculosis pathogenesis. The cell wall mainly contains mycolic acid which is responsible for cell viability.
This cell wall is extremely hydrophobic and is responsible for its survival and virulence. The outer cell wall includes a long chain of mycolic acid (MAs) which are transported from the inner membrane as Trehalose Monomycolates (TMMs) with the help of a transporter to outside the cell wall where it gets incorporated as Trehalose Dimycolates (TDMs), along with noncovalently binded lipids. This distinct structure of the outer cell wall of Mtb is very rigid and extremely impermeable to many anti TB Drugs. Hence, TMMs transport and biosynthesis is essential for the survival of Mtb.3, 4
MmpL3 (Mycobacterial Membrane Protein Large 3) which belongs to RND family (Resistance Nodulation and cell Division) is a lipid transporter that binds with the Trehalose Monomycolates and transfer it to the outer cell wall from the cytoplasm where it is required for cell wall integrity and biosynthesis. MmpL3 is one of the most recent targets for development of new drug for anti-tubercular therapy. Several compound which act as inhibitors of MmpL3 have been reported so far inhibitors like BM 212, SQ109, adamantyl urea derivatives that have shown promising inhibitory activity in vitro.
Over the years, the study of QSAR (Quantitative Structure Activity Relationship) has emerged as an adept technique which used as an important and efficient tool in for drug discovery and development.5
QSAR is a mathematical model of statistical correlation between biological activity and deviation structural properties in a series of chemical compounds. The QSAR helps in predicting the activity of unknown compounds using a structurally similar QSAR model. The molecular descriptors (the molecular properties used in QSAR) can be either 2D (Hydrophobicity, Bond length, bond angle, dipole moments, steric effects, electronic properties, pKa in ionic compounds etc.) or 3D (involves stereochemistry, optical activity, active site interaction etc.)6,7,8,9.
Here, a set of 1-Adamantyl-3-Heteroaryl Urea derivatives with MmpL3 inhibitory activity were selected from the literature to study and design 3D and 2D QSAR models and structural features required for MmpL3 inhibitory activity were identified. The data reported by the various QSAR models provides guidance for the designing of structurally new adamantyl urea inhibitors with potential activity against MmpL3 of M. tuberculosis.
Experimental:
MATERIALS AND METHODS:
All the in silico experiments were conducted using the Schrodinger Software. The chemical structures were drawn and prepared using Marvin Sketch from ChemAxon. The alignment of the ligand, generation of atom based 3D QSAR models and fingerprint based 2D QSAR were performed using Maestro version 11.4 (Schrodinger Inc.) and Canvas software from the Schrodinger Package in using an Intel Core i3-4160 processor with 4GB RAM and Intel Haswell graphics card using a Linux Ubuntu 18.04.1 LTS operating system10,11,12,13..
Molecular Dataset:
A set of 48 structures Table 1. Of 1-Adamantyl-3-Heteroaryl Urea derivatives having MmpL3 inhibitory property in M. tuberculosis H7RV strain were selected from the literature to generate QSAR models. The structure variation and the relation to its wide range of biological activity served as an ideal data for generating suitable QSAR models for predicting activity. The MIC activity data [MIC H37RV (µM)] for the above derivatives was used after being converted to the logarithmic scale pMIC H37RV as the depending variables in 3D and 2D QSAR studies14, 15,16,17,18..
Ligand Alignment:
It is one of the most crucial step to ensure the generation of most precise and accurate 3D QSAR model. It helps in comparing and studying the relation between the deviations of the structures in the dataset. The structures in the data set are aligned in such a way that they are superimposed over each other, this was achieved using flexible ligand alignment in the maestro program of the Schrodinger software. [Fig.1.]
Fig.1. Flexible Ligand Alignment of the selected dataset from the literature
Building Atom based 3D QSAR model.
Hereby, using the above dataset atom based 3D QSAR was built. From this dataset 70% were chosen as training set and 30% as test set to generate the best possible QSAR model with 6 PLS (Partial least square) factors to obtain a more precise cross validated coefficient R2 with minimum standard deviation (<0.3-0.2). The QSAR model with the value of R2 >> 0.9 or equal to 1 is usually preferred. This in turn helps in generating a better and more accurate cross validated value of q2 (>>0.7). This was carried out using Atom Based QSAR in Phase application of Maestro (Schrodinger).19, 20, 21 Refer Table1.
Building Fingerprint based 2D QSAR Models:
The Canvas provides seven 2D fingerprint based models. They are explained briefly as follows: Atom pair, Atom Triplet, Dendritic, linear, molprint, radial and topological fingerprint models.
Here the 2D canvas fingerprints are associated with Kernel based PLS in order to generate precise and suitable QSAR models that represents the atoms in the structure and give information about the overall beneficial and non-beneficial attributes of the given dataset. The same set of test and training used in atom based 3D QSAR was utilised in the fingerprint based 2D QSAR model generation. 2D QSAR analysis see Table 2.
Table 1. Structure, Predicted and experimental activity of 1-Adamantyl-3-Heteroaryl Urea derivatives with anti-tubercular activity utilised in the test and training set in QSAR model.
|
Compound |
Structure |
MIC H37RV (µM) |
pMIC H37RV |
QSAR Set |
Predicted Activity |
Predicted Error |
|
1 |
0.00003 |
10.511 |
Training |
10.2366 |
-0.274413 |
|
|
46 |
0.00032 |
9.502 |
Test |
8.63846 |
-0.863198 |
|
|
6 |
0.00116 |
8.935 |
Training |
8.91062 |
-0.0244011 |
|
|
2 |
0.00123 |
8.909 |
Training |
9.25025 |
0.341301 |
|
|
4 |
0.00135 |
8.868 |
Training |
9.16503 |
0.295597 |
|
|
28 |
0.00237 |
8.626 |
Training |
8.40991 |
-0.215621 |
|
|
35 |
0.00238 |
8.623 |
Test |
0.096095 |
0.437895 |
|
|
51 |
0.00247 |
8.608 |
Training |
7.96568 |
-0.642469 |
|
|
24 |
|
0.00491 |
8.309 |
Training |
8.63846 |
0.329927 |
|
43 |
0.00493 |
8.307 |
Test |
8.21433 |
-0.0928476 |
|
|
37 |
0.00512 |
8.29 |
Training |
7.89887 |
-0.391441 |
|
|
33 |
0.00535 |
8.271 |
Training |
8.31264 |
0.0412451 |
|
|
50 |
0.01035 |
7.985 |
Test |
7.55453 |
-0.430476 |
|
|
52 |
0.01035 |
7.985 |
Training |
7.65847 |
-0.326596 |
|
|
34 |
0.01074 |
7.969 |
Training |
7.91737 |
-0.0516071 |
|
|
32 |
0.01128 |
7.948 |
Test |
7.90751 |
-0.0400336 |
|
|
13 |
0.01469 |
7.833 |
Training |
7.61688 |
-0.216196 |
|
|
47 |
0.0227 |
7.644 |
Test |
6.80983 |
-0.834181 |
|
|
21 |
0.02392 |
7.621 |
Training |
7.35433 |
-0.266974 |
|
|
39 |
0.03951 |
7.403 |
Training |
7.96568 |
0.562346 |
|
|
38 |
0.04134 |
7.384 |
Training |
7.55453 |
0.170889 |
|
|
42 |
0.04133 |
7.384 |
Training |
7.65847 |
0.274769 |
|
|
27 |
0.0454 |
7.343 |
Training |
7.02542 |
-0.317557 |
|
|
15 |
0.04606 |
7.337 |
Test |
7.24852 |
-0.0881216 |
|
|
45 |
0.04784 |
7.32 |
Training |
7.35433 |
0.0340912 |
|
|
7 |
0.05412 |
7.267 |
Training |
7.38997 |
0.123288 |
|
|
8 |
0.05464 |
7.263 |
Training |
7.18819 |
-0.074317 |
|
|
12 |
0.05624 |
7.25 |
Training |
7.23276 |
-0.0172287 |
|
|
9 |
0.05807 |
7.236 |
Training |
7.19772 |
-0.0383465 |
|
|
14 |
|
0.06633 |
7.178 |
Training |
7.00804 |
-0.170238 |
|
41 |
0.08669 |
7.062 |
Training |
7.25519 |
0.193142 |
|
|
36 |
0.09047 |
7.044 |
Test |
6.94194 |
-0.101564 |
|
|
18 |
0.09179 |
7.037 |
Training |
6.75326 |
-0.283934 |
|
|
23 |
0.09806 |
7.009 |
Test |
6.80983 |
-0.198697 |
|
|
44 |
0.18224 |
6.739 |
Training |
6.8286 |
0.0892343 |
|
|
22 |
0.19133 |
6.718 |
Training |
6.77585 |
0.0576337 |
|
|
25 |
0.28228 |
6.549 |
Test |
6.81061 |
0.261293 |
|
|
40 |
0.29033 |
6.537 |
Training |
6.29932 |
-0.237789 |
|
|
29 |
|
0.32279 |
6.491 |
Training |
6.58683 |
0.0957547 |
|
30 |
0.33293 |
6.478 |
Test |
6.54856 |
0.0709141 |
|
|
31 |
0.34557 |
6.461 |
Training |
6.47593 |
0.0144623 |
|
|
19 |
0.45731 |
6.34 |
Test |
6.37966 |
0.03987 |
|
|
20 |
0.73169 |
6.136 |
Test |
6.70511 |
0.569433 |
|
|
17 |
0.73434 |
6.134 |
Training |
6.43449 |
0.300391 |
|
|
16 |
0.73701 |
6.133 |
Training |
6.80809 |
0.675562 |
Table 2. Fingerprint based 2D QSAR data set.
|
Ligand molecule |
MIC H37Rv (µM) |
pMIC |
fp linear 1 |
fp radial 2 |
fp dendritic 3 |
fp molprint 2 d4 |
fp atompairs
|
fp atomtripleets 5 |
fp topological 7 |
|
1 |
0.0000 |
10.511 |
266 |
67 |
188 |
15 |
106 |
767 |
22 |
|
46 |
0.000 |
9.502 |
237 |
61 |
180 |
15 |
99 |
539 |
22 |
|
6 |
0.001 |
8.935 |
292 |
70 |
226 |
19 |
133 |
893 |
29 |
|
2 |
0.001 |
8.909 |
249 |
61 |
188 |
15 |
103 |
682 |
22 |
|
4 |
0.001 |
8.868 |
184 |
66 |
127 |
14 |
95 |
545 |
15 |
|
28 |
0.002 |
8.626 |
237 |
61 |
180 |
15 |
99 |
538 |
22 |
|
35 |
0.002 |
8.63 |
352 |
69 |
224 |
16 |
90 |
569 |
28 |
|
51 |
0.002 |
8.608 |
279 |
66 |
184 |
16 |
103 |
617 |
23 |
|
24 |
0.005 |
8.309 |
237 |
61 |
180 |
15 |
99 |
539 |
22 |
|
43 |
0.005 |
8.290 |
277 |
70 |
207 |
17 |
120 |
723 |
26 |
|
37 |
0.005 |
8.290 |
229 |
60 |
168 |
15 |
96 |
532 |
20 |
|
33 |
0.005 |
8.271 |
218 |
57 |
157 |
14 |
84 |
432 |
20 |
|
50 |
0.010 |
7.985 |
269 |
59 |
177 |
15 |
94 |
518 |
21 |
|
52 |
0.010 |
7.985 |
261 |
64 |
198 |
16 |
105 |
617 |
25 |
|
34 |
0.010 |
7.969 |
218 |
57 |
157 |
14 |
84 |
432 |
20 |
|
32 |
0.011 |
7.948 |
197 |
52 |
37 |
13 |
66 |
315 |
18 |
|
13 |
0.015 |
7.833 |
219 |
72 |
158 |
16 |
142 |
1084 |
17 |
|
47 |
0.023 |
7.833 |
219 |
55 |
157 |
14 |
84 |
432 |
20 |
|
21 |
0.024 |
7.621 |
197 |
49 |
137 |
13 |
66 |
315 |
18 |
|
39 |
0.040 |
7.403 |
279 |
66 |
184 |
16 |
103 |
620 |
23 |
|
38 |
0.041 |
7.384 |
269 |
59 |
177 |
15 |
94 |
521 |
21 |
|
42 |
0.041 |
7.384 |
261 |
64 |
198 |
16 |
105 |
617 |
25 |
|
27 |
0.045 |
7.343 |
218 |
55 |
157 |
14 |
84 |
432 |
20 |
|
15 |
0.046 |
7.337 |
196 |
59 |
136 |
14 |
72 |
981 |
18 |
|
45 |
0.048 |
7.320 |
197 |
49 |
137 |
13 |
66 |
315 |
18 |
|
7 |
0.054 |
7.267 |
310 |
84 |
230 |
22 |
203 |
1629 |
27 |
|
8 |
0.055 |
7.263 |
325 |
84 |
237 |
2 |
217 |
1835 |
28 |
|
12 |
0.056 |
7.250 |
331 |
81 |
270 |
22 |
207 |
1627 |
33 |
|
9 |
0.058 |
7.236 |
311 |
80 |
239 |
21 |
191 |
1443 |
29 |
|
14 |
0.066 |
7.178 |
164 |
55 |
116 |
12 |
65 |
326 |
14 |
|
41 |
0.087 |
7.062 |
237 |
63 |
170 |
15 |
96 |
518 |
22 |
|
36 |
0.090 |
7.044 |
210 |
54 |
149 |
14 |
81 |
428 |
18 |
|
18 |
0.092 |
7.037 |
207 |
59 |
143 |
14 |
73 |
381 |
19 |
|
23 |
0.098 |
7.009 |
218 |
55 |
157 |
14 |
84 |
432 |
20 |
|
44 |
0.182 |
6.739 |
208 |
57 |
151 |
14 |
79 |
399 |
19 |
|
22 |
0.191 |
6.718 |
197 |
51 |
137 |
13 |
74 |
353 |
18 |
|
25 |
0.282 |
6.549 |
240 |
57 |
189 |
15 |
95 |
512 |
24 |
|
40 |
0.290 |
6.537 |
344 |
70 |
227 |
18 |
123 |
771 |
29 |
|
29 |
0.323 |
6.491 |
240 |
57 |
189 |
15 |
95 |
512 |
24 |
|
30 |
0.333 |
6.478 |
260 |
62 |
207 |
16 |
109 |
624 |
25 |
|
31 |
0.346 |
6.461 |
237 |
55 |
186 |
15 |
92 |
508 |
24 |
|
19 |
0.457 |
6.340 |
163 |
55 |
115 |
12 |
61 |
321 |
14 |
|
20 |
0.732 |
6.136 |
196 |
58 |
139 |
14 |
76 |
383 |
18 |
|
17 |
0.734 |
6.134 |
164 |
55 |
116 |
17 |
66 |
324 |
14 |
|
16 |
0.737 |
6.133 |
206 |
58 |
142 |
14 |
72 |
386 |
19 |
RESULT AND DISCUSSION:
Atom Based 3D QSAR analysis:
The atom based 3D QSAR models were developed on the basis of the flexible ligand alignment19,20,21. The predicted activity as well the predicted errors along with the test and training set selection of the dataset is displayed on Table 1. This model was chosen due to its high Q2 (0.8070) and R2 (0.9128) which proves it was credible and precise. The statistical parameters of the atom based QSAR constructed based on 6 PLS factors are presented at the Table 3. The F factor and the standard deviation were 47.1 and 0.3078 respectively. The scatter plots of the test and training set of the atom based 3D QSAR are shown in Fig2.
Table 3. Atom based 3D QSAR Statistics
|
Factors |
SD |
R2 |
F |
Q^2 |
|
1 |
0.7185 |
0.4369 |
24.8 |
0.1978 |
|
2 |
0.6280 |
0.5833 |
21.7 |
0.4807 |
|
3 |
0.5170 |
0.7267 |
26.6 |
0.6520 |
|
4 |
0.3920 |
0.8481 |
40.5 |
0.7925 |
|
5 |
0.3650 |
0.8728 |
38.4 |
0.7925 |
|
6 |
0.3078 |
0.9128 |
47.1 |
0.8070 |
Test data set plot
Training Dataset Plot
Figure 2. Scatter plot for Atom Based 3D QSAR showing relation between activity observed and the predicted activity 6
3D QSAR visualization:
The statistics Atom type fractions are seen in Table 4. The QSAR study was visualised in fields such as Hydrogen Bond Donor, negative ionic, hydrophobic, electron withdrawing and others factors which helped us to gain insight regarding the regions of the chemical framework of the adamantyl urea derivatives in the dataset and information regarding addition or removal of particular groups which causes either positive or negative effect on the anti-tubercular activity of the molecule. The visualisation of the QSAR model are shown in Figure3. The analysis was done using the ligand molecule 1 as the reference as it has the highest MmpL3 inhibitory activity among the chosen data set and 16 as molecule with the least inhibitory activity and 42 as the molecule showing the average MmpL3 inhibitory activity. The visualisation was focused on the Hydrogen Bond Donor, negative ionic, hydrophobic, electron withdrawing and others factors in which it is shown that the dark blue and red colour regions represent the positive and negative effects on the activity.
Table 4. Atom Type Fractions
|
Factors |
H-bond donor |
Hydrophobic/non-polar |
Negative ionic |
Electron-withdrawing |
Other |
|
1. |
0.100787 |
0.455793 |
0.007573 |
0.396786 |
`0.039061 |
|
2. |
0.054826 |
0.461581 |
0.016217 |
0.384467 |
0.082910 |
|
3. |
0.022115 |
0.508655 |
0.022350 |
0.368735 |
0.078146 |
|
4. |
0.013001 |
0.573151 |
0.019799 |
0.308392 |
0.085658 |
|
5. |
0.012788 |
0.570752 |
0.004901 |
0.320661 |
0.090899 |
|
6. |
0.009478 |
0.606266 |
0.010302 |
0.268104 |
0.105851 |
3.1 Hydrogen bond Donor
3.2 Hydrophobic
3.3 Electron Withdrawing
3.4 Negative ionic:
Figure 3. Atom based 3D QSAR visualisation in various fields as mentioned above.
Fingerprint based 2D QSAR study and visualization:
The fingerprint based models in atom pair, atom triplet, dendritic, molprint, linear, radial and topological models were developed using the dataset in Table222, 23, 24,25. The topological model was found out to be the most suitable model among all the fingerprints based 2D QSAR model which helps in predicting the activity more precisely with the validating factors of training set R2 and standard deviation values as 0.9644 and 0.2005 respectively and test validating set Q2 and RMSE values as 0.6758 and 0.5386 respectively with six KPLS factors. The statistical data of the Fingerprint based 2D QSAR model are presented at the Table 5. The 2D QSAR is visualised for all the fingerprint model with the ligand molecule 1 as the reference as it has the highest MmpL3 inhibitory activity among the chosen data set and 16 as the least inhibitory activity and 42 and the average. The 2D QSAR fingerprint visualisation of the topological model can be seen in figure 4. It is shown such that the red and blue colour regions represent the positive and negative effects on the activity.
Table 5. Fingerprint based 2d qsar model statistics
Fingerprint based 2D QSAR (fp topological_7 model) Statistics
Training Set Test Set
|
Kpls Factors |
SD |
R2 |
|
1 |
0.3896 |
0.8406 |
|
2 |
0.2869 |
0.9163 |
|
3 |
0.2304 |
0.9478 |
|
4 |
0.2159 |
0.9557 |
|
5 |
0.2075 |
0.9604 |
|
6 |
0.2005 |
0.9644 |
|
Kpls Factors |
RMSE |
Q2 |
|
1 |
0.634 |
0.5506 |
|
2 |
0.566 |
0.6419 |
|
3 |
0.5036 |
0.7166 |
|
4 |
0.5093 |
0.7102 |
|
5 |
0.5288 |
0.6874 |
|
6 |
0.5386 |
0.6758 |
Figure 4. Fingerprint based 2D QSAR topological based model visualisation
CONCLUSION:
The atom based 3D QSAR model and fingerprint based canvas 2D QSAR model were designed and the most precise and suitable model was generated to predict the MmpL3 inhibitory activity of 1-Adamantyl-3-Heteroaryl Urea derivatives. The given study indicates that the ligand molecule 1 has high anti-tubercular activity with various possibilities of structural alteration to develop potential molecule with significant MmpL3 inhibitory activity and also predict the activity of any unknown derivative and determine its pMIC values. The data reported by the above QSAR models provides guidance for the designing of structurally new adamantyl urea inhibitors with potential activity against MmpL3 of M. tuberculosis.
REFERENCES:
1. Singh S, Kumar S. Tuberculosis in India: Road to elimination. Int J Prev Med 2019; 10:114.
2. World Health Organisation. Global Tuberculosis Report 2019. Accessed on January 2020.
3.
Chih-Chia Su, Philip A. Klenotic,
Jani Reddy Bolla, Georgiana E. Purdy, Carol V. Robinson, Edward W. MmpL3 is a lipid
transporter that binds Trehalose Monomycolates and phosphatidylethanolamine. Proceedings of the National Academy of Sciences
2019;116 (23) 11241-11246
4. Grzegorzewicz AE, Pham H, Gundi VA, et al. Inhibition of mycolic acid transport across the Mycobacterium tuberculosis plasma membrane. Nat Chem Biol. 2012; 8(4):334‐341.
5. Rayasam GV. MmpL3 a potential new target for development of novel anti-tuberculosis drugs. Expert Opin Ther Targets. 2014; 18(3):247‐256.
6. Kumar L, Verma R. Molecular docking based approach for the design of novel flavone analogues as inhibitor of beta-hydroxyacyl-ACP dehydratase HadAB complex. Research J. of Pharm. and tech. 10(8); 2439-2445.
7. Lohit T, Kumar L, Verma R. Design, Molecular Docking, ADME Analysis and Molecular Dynamics Studies of Novel Acetylated Schiff bases as COX-2 inhibitors. Research J. Pharm. and Tech. 13(4); 1901-1906.
8. Ruchi V, Indira B, Mradul T, Varadaraj BG· Gautham GS. In silico studies, synthesis and anticancer activity of novel diphenyl ether-based pyridine derivatives. Molecular diversity. 23; 2019: 541–554.
9. Ruchi V, Helena IMB, Kriti A, Indira B., Mradul T, Varadral GB, Gautham GS. Synthesis, antitubercular evaluation, molecular docking and molecular dynamics studies of 4,6-disubstituted-2-oxo-dihydropyridine-3-carbonitriles. Journal of molecular structure.1197:2019:117-133.
10. Ruchi V, Helena IMB, Kriti A, Indira B., Mradul T, Varadral GB, Gautham GS. Synthesis, evaluation, molecular docking, and molecular dynamics studies of novel N-(4-[pyridin-2-yloxy]benzyl) arylamine derivatives as potential antitubercular agents. Drug Dev Res. 2020;81:315–328.
11. Prem SM, Ravichandiran V, Aanandhi MV. Design, Synthesis and in silico molecular docking study of N-carbamoyl-6-oxo-1-phenyl-1, 6-dihydropyridine-3-carboxamide derivatives as fibroblast growth factor 1 inhibitor. Research Journal of Pharmacy and technology. 10(8); 2017:2527-2534.
12. Habeela JN, Raja MKMM. In silico molecular docking studies on the chemical constituents of clerodendrum phlomidis for its cytotoxic potential against breast cancer markers. Research Journal of Pharmacy and technology. 11 (4); 1612-1618:2018.
13. Surakanti R, Eppakayala L, Ramchander M, Venkat RP. Synthesis and molecular docking for anti-inflammatory and anti-mitotic activities of (S)-(2-Methyl-4-(1-Phenyl-1h-Thieno/Furan [3, 2-C] Pyrazol-3-yl) Piperazin-1-yl) (Pyridin-2-yl) Methanone. Asian Journal of Research in Chemistry. 10(4); 2017:582-586.
14. Hemalatha K, Chakkaravarthi V, Ganesa Murthy K, Kayatri R, Girija K. Molecular Properties and Docking Studies of Benzimidazole Derivatives as Potential Peptide Deformylase Inhibitors. Asian Journal of Research in Chemistry. 7(7); 2014: 644-648.
15. North, E.J., Scherman, M.S., Bruhn, D.F., Scarborough, J.S., Maddox, M.M., Jones, V., Grzegorzewicz, A., Yang, L., Hess, T., Morisseau, C., Jackson, M., McNeil, M.R., Lee, R.E. Design, synthesis and anti-tuberculosis activity of 1-adamantyl-3- heteroaryl ureas with improved in vitro pharmacokinetic properties. Bioorg Med Chem 2013; 21 (9), pp. 2587-2599
16. Wadhwa P, Bagchi S, Sharma A. 3D-QSAR Selectivity Analysis of 1-Adamantyl-3-Heteroaryl Urea Analogs as Potent Inhibitors of Mycobacterium tuberculosis. Curr Comput Aided Drug Des. 2015; 11(2):164‐183.
17. Ul-Haq Z, Effendi JS, Ashraf S, Bkhaitan MM. Atom and receptor based 3D QSAR models for generating new conformations from pyrazolopyrimidine as IL-2 inducible tyrosine kinase inhibitors. J Mol Graph Model. 2017; 74: 379‐395.
18. Wang M, Li W, Wang Y, Song Y, Wang J, Cheng M. In silico insight into voltage-gated sodium channel 1.7 inhibition for anti-pain drug discovery. J Mol Graph Model. 2018; 84:18‐28.
19. Kristam R, Parmar V, Viswanadhan VN. 3D-QSAR analysis of TRPV1 inhibitors reveals a pharmacophore applicable to diverse scaffolds and clinical candidates. J Mol Graph Model. 2013; 45: 157‐172.
20. An Y, Sherman W, Dixon SL. Kernel-based partial least squares: application to fingerprint-based QSAR with model visualization. J Chem Inf Model. 2013; 53(9):2312‐2321.
21. Kunal Roy, Rudra Narayan Das. A Review on Principles, Theory and Practices of 2D-QSAR. Curr. Drug Metab, 2014; 15, 346-379.
22. Ganatra S. H., Patle M. R, Bhagat G. K. Studies of Quantitative Structure-Activity Relationship (QSAR) of Hydantoin Based Active Anti-Cancer Drugs. Asian J. Research Chem. 2011; 4(10): 1643-1648.
23. R. S. Kalkotwar, R. B. Saudagar. Synthesis and QSAR Studies of Some 2,5-Diaryl Substituted-1,3,4-Oxadiazole Derivatives. Asian J. Research Chem. 2013, (11): 985-991.
24. Ashish Mullani, J. I. Disouza. Synthesis and QSAR study of N-Substituted [5-(1H-1,2,4-Triazol-5-yl)pyridine-2-YL]methanimine Derivatives as potential Antibacterial. Asian J. Research Chem. 2015, 8(9): 561-565.
25. V. S. Kawade, S. S. Kumbhar, P. B. Choudhari, M. S. Bhatia. 3D QSAR and Pharmacophore Modelling of some Pyrimidine Analogs as CDK4 Inhibitors. Asian J. Research Chem 2015; 8(4): 231-235.
Received on 28.05.2020 Modified on 23.11.2020
Accepted on 02.01.2021 © RJPT All right reserved
Research J. Pharm.and Tech 2021; 14(12):6321-6329.
DOI: 10.52711/0974-360X.2021.01093